Is Curve Llamalend a Good Investment?

BValue
B-Risk
|Lending
Loading price data...
TVL$61M
FDV$483M
TVL/FDV0.13x
Risk GradeB-
Value GradeB

Value Accrual: Does the Curve Llamalend Token Capture Value?

Curve Llamalend scores B on Hindenrank's value accrual framework (68/100), indicating solid value fundamentals with room for improvement in one or two dimensions. Scored on Hindenrank's Stablecoin framework.

Scored as: Stablecoin
Peg Stability
19/25
Reserve Transparency
23/25
Regulatory Compliance
10/25
Adoption Breadth
16/25

Protocol Health: Is Curve Llamalend Still Growing?

Curve Llamalend's vitality risk score is 4/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — Curve Llamalend is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.

Risk-Adjusted View: Is the Upside Worth the Risk?

Risk-Adjusted Position

Blue Chip
High Value
Medium Value
Low Value
High Risk
High Risk Play
Risky
Avoid
Medium Risk
Promising
Neutral
Weak
Low Risk
Curve Llamalend
Safe but Stale
Dead Money
See all Blue Chip protocols →

Curve Llamalend lands in the Blue Chip quadrant — combining strong value accrual (B) with low risk (B-). This is the most favorable risk-adjusted position, suggesting the protocol delivers real economic value without excessive risk. Protocols in this quadrant are typically suitable as core portfolio holdings.

Risk Context

Curve Llamalend carries a risk grade of B- (34/100), classified as moderate risk — some novel mechanisms, generally well-understood. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: LLAMMA soft-liquidation mechanism is novel and has limited stress-testing through severe, prolonged multi-week price declines

Read our full safety analysis →

Where Curve Llamalend Sits Among Lending Peers

On risk, Curve Llamalend ranks #39 of 99 Lending protocols (above-median). That's 3 points safer than the sector average of 37/100.

The closest peer by risk profile is Ajna Protocol (grade B-, 34/100). See the side-by-side comparison to weigh their tradeoffs.

Should you buy Curve Llamalend?

Curve Llamalend scores B on Hindenrank's value accrual framework, placing it among the above-average Lending protocols. Scored on the Stablecoin framework (68/100). On the risk side, Curve Llamalend carries a B- grade (34/100), which is moderate risk — some novel mechanisms, generally well-understood. The combined risk-value position places Curve Llamalend in the Blue Chip quadrant.

Curve Llamalend investment outlook for 2026

With $61M in total value locked and FDV of $483M, giving a TVL/FDV ratio of 0.13, Curve Llamalend's fundamentals support the current valuation from a usage perspective. Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.

This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology

Weekly Commentary

Pro

Week of March 3, 2026

Curve Llamalend's B- risk grade reflects solid engineering — the soft-liquidation LLAMMA mechanism is genuinely novel — but a D+ value score exposes the core problem: fees flow to veCRV holders, not to Llamalend itself, leaving this $77M lending market as a feature of Curve rather than a standalone value engine. It sits squarely in Dead Money territory — safe enough to park capital, but with no clear catalyst to reward holders beyond the broader Curve ecosystem's fortunes.

Related Lending Investment Analyses

Related Lending Safety Analyses

Get risk alerts before it's too late

Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.

Investment analysis uses Hindenrank's value accrual framework across four dimensions: fee capture, token distribution, emission sustainability, and competitive moat. Higher score = better value accrual. Combined with our eight-dimension risk rubric for risk-adjusted positioning. This is not financial advice.